Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
NCT01059422
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Tuberculosis
Interventions
DRUG:
Raltegravir; Abacavir/Lamivudine
Sponsor
Central Institute of Epidemiology, Moscow, Russia
Collaborators
[object Object]